Vision & Strategy: Solar Energy in Ontario, Canada
Previously focused on oil & gas in Canada, Berkley Renewables is pursuing opportunities in the Solar Energy sector. Our long-term growth strategy is to become a leader in solar energy development in Canada. We're currently focused on developing Solar PV projects in Ontario, operating within the province's Green Energy Act. Working with our subsidiary Solar Flow-Through General Partner Ltd, (part of Solar Flow Through Funds), we have developed a unique flow-through investment vehicle for investors to participate in Ontario's rapid solar energy growth and innovation. We use these funds to invest in solar power projects that have been qualified under the Ontario's Independent Energy System Operator (IESO) Feed-in-Tariff (FIT) program.
Recent Investment: Life Sciences/Cell Replication
Our investment in
RepliCel Life Sciences Inc. reflects our belief that cell replication technology holds enormous promise for human health in both the near and long term. Replicel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.
RepliCel's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, UV-damaged or aged skin, and pattern baldness. RepliCel is also developing a proprietary, next-generation injection device for delivery of its RCH-01 and RCS-01 products that also has uses with other dermatological injection procedures.
